AngioDynamics, Inc. v. Biolitec AG

946 F. Supp. 2d 205, 2013 WL 1567739, 2013 U.S. Dist. LEXIS 52228
CourtDistrict Court, D. Massachusetts
DecidedApril 11, 2013
DocketC.A. No. 09-cv-30181-MAP
StatusPublished
Cited by10 cases

This text of 946 F. Supp. 2d 205 (AngioDynamics, Inc. v. Biolitec AG) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
AngioDynamics, Inc. v. Biolitec AG, 946 F. Supp. 2d 205, 2013 WL 1567739, 2013 U.S. Dist. LEXIS 52228 (D. Mass. 2013).

Opinion

MEMORANDUM AND ORDER REGARDING PLAINTIFF’S EMERGENCY MOTION FOR CONTEMPT (Dkt. No. 205)

PONSOR, District Judge.

I. INTRODUCTION

This case originally arose out of a private commercial dispute between the par[210]*210ties. Over the last month, however, the case has turned into a challenge to the very foundation of the rule of law. Defendants Wolfgang Neuberger, Biolitec AG (“BAG”), and Biomed Technology Holdings, Ltd. (“Biomed”) flagrantly and intentionally violated a preliminary injunction issued by this court.1 Plaintiff brought this motion for civil contempt in response to Defendants’ notice to the court that they had completed the action forbidden by the preliminary injunction. The court will enter coercive sanctions to ensure Defendants’ prompt compliance with the order. These coercive sanctions will remain in place until Defendants effectively restore the parties to the status quo ante. The court will also refer this case to the United States Attorney for prosecution for criminal contempt.

II. BACKGROUND

For purposes of this motion, the court has no need to go into the detailed relationship among the parties and the substance of the private commercial dispute. That material has been extensively outlined in prior decisions. AngioDynamics, Inc. v. Biolitec, Inc., 2011 WL 3157312, *1-2 (D.Mass. July 25, 2011); AngioDynamics, Inc. v. Biolitec AG, 910 F.Supp.2d 346 (D.Mass.2012). However, a brief background of the events leading up to the motion at hand is required.

In August 2012, Plaintiff became aware that Defendant BAG planned to complete a merger with its Austrian subsidiary entity, Biolitec Unternehmensbeteiligungs I AG (“BUIAG”). Defendant BAG set a shareholders’ meeting for August 30, 2012, to vote on the proposed merger of BAG into BUIAG. Following the proposed merger, the new entity would hold all assets and liabilities previously held by BAG, and .shareholders in BAG would have their shares converted into shares of the new entity. BAG publicly announced that the 75% ownership share of Defendant CEO Wolfgang Neuberger in BAG guaranteed that his plan would be approved by a majority of the shareholders.

Plaintiff filed for a preliminary injunction to prevent Defendants from completing the merger. Plaintiff alleged that the merger would place BAG’S assets out of its reach, as American judgments are unenforceable in Austria. On August 29, 2012, Judge Zobel granted Plaintiffs Motion for a TRO and Preliminary Injunction to bar this merger. The injunction restrained Defendants from:

• “carrying] out the proposed ‘downstream merger’ of Biolitec AG with its Austrian subsidiary;
• “alienatfing], disposing] of, selling] dissipating], encumbering], or otherwise transfer[ing] any ownership interest it holds in any other defendant during the duration of this Order; and
• “alienating], disposing] of, selling] dissipating], encumbering], or otherwise transfer[ing] any interest it may have in any property during the duration of this Order, except that this Order shall not preclude the defendants from taking such actions as are reasonable and necessary to the ongoing and continued operation of the business of Biolitec, Inc., Biolitec AG, and Biomed Technology Holdings, Ltd. in the ordinary course of business, including the payment of reasonable attorneys’ fees for the provision of legal services; and ex[211]*211cept that this Order shall not apply to the reasonable and necessary personal and living expenses of defendant Wolfgang Neuberger.”

(Dkt. No. 126.) The injunction further restrained, with minor exceptions, Defendants’ use of their property pending a further order of this court.

On September 6, 2012, defense counsel informed the court that, despite Judge Zobel’s order, Defendant BAG had proceeded with the shareholders’ meeting and vote. (Dkt. No. 133 ¶ 5.) Defendants did not inform the minority shareholders of the TRO. (Dkt. No. 136-1, Sept. 10, 2010 Reynolds Decl. ¶ 11.) Given Defendant Neuberger’s three-quarter share in the company, it was not surprising that the vote in favor of the merger passed by a wide margin.

The convening of the shareholders’ meeting and the vote in favor of the merger, in the teeth of the preliminary injunction, raised troubling questions about Defendants’ good faith. Their argument in opposition to the issuance of the preliminary injunction was anchored on their contention that the injunction would bar the meeting and vote, yet they immediately proceeded with the vote right after the injunction issued. Reassured by Defendants that the vote in favor of the merger did not, technically, effectuate the merger, and that Defendants still intended to hold off on the merger out of respect for the injunction, this court concluded that, since the formal merger of BAG into the Austrian entity had not occurred, no outright violation of the preliminary injunction had taken place.

On September 13, 2012, after hearing oral argument, this court reaffirmed the preliminary injunction entered by Judge Zobel. (Dkt. No. 141.) Defendants moved for reconsideration of the preliminary injunction and requested an evidentiary hearing. (Dkt. No. 144.) The court declined the request to reconsider the preliminary injunction and hold an evidentiary hearing on December 14, 2012, in a lengthy decision justifying the issuance of the preliminary injunction. AngioDynamics, Inc. v. Biolitec AG, 910 F.Supp.2d 346 (D.Mass.2012).

Defendants immediately appealed the preliminary injunction to the First Circuit asking for expedited resolution and also requesting that the First Circuit modify the preliminary injunction pending the appeal pursuant to Fed.R.Civ.P. 8(a)(2). On February 4, 2013, the First Circuit denied Defendants’ motion for modification. Defendants then filed in this court an emergency motion to vacate the order pursuant to Fed.R.Civ.P. 60(b)(2). (Dkt. No. 190) That motion was also denied for failure to raise sufficient new evidence to justify altering the preliminary injunction. (Dkt. No. 195)

Despite the continued affirmance of the preliminary injunction by this court and the First Circuit, Defendants notified this court on March 15, 2013, that:

Biolitec AG’s downstream merger with its Austrian subsidiary has been completed pursuant to the direction of Biolitec AG’s Supervisory Board. The merger was completed [on] March 15, 2013, when the Commercial Court of Vienna approved registration of the merger in Austria.

(Dkt. No. 199, Defs.’ Notice of Completion of BAG’S Downstream Merger 1.)

Unsurprisingly, this concession prompted Plaintiff to file the current emergency motion for contempt.

On April 1, the First Circuit heard oral arguments on Defendants’ expedited appeal. In an unusually prompt turnaround, the First Circuit upheld the preliminary injunction on the same day. Two days [212]*212later, this court heard oral arguments on Plaintiffs motion for contempt. At that hearing, this court ordered individual Defendant Neuberger to appear in person at a hearing on April 10 to show cause why he should not be held in civil or criminal contempt.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carter v. Quicken Loans, LLC
D. Massachusetts, 2023
Geiman v. BR Steel, LLC
D. Massachusetts, 2020
AngioDynamics, Inc. v. Biolitec AG
305 F. Supp. 3d 300 (District of Columbia, 2018)
AngioDynamics, Inc. v. Biolitec AG
780 F.3d 429 (First Circuit, 2015)
AngioDynamics, Inc. v. Biolitec, Inc.
775 F.3d 550 (Second Circuit, 2015)
AngioDynamics, Inc. v. Biolitec AG
991 F. Supp. 2d 283 (D. Massachusetts, 2014)
AngioDynamics, Inc. v. Biolitec, Inc.
974 F. Supp. 2d 1 (D. Massachusetts, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
946 F. Supp. 2d 205, 2013 WL 1567739, 2013 U.S. Dist. LEXIS 52228, Counsel Stack Legal Research, https://law.counselstack.com/opinion/angiodynamics-inc-v-biolitec-ag-mad-2013.